Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells
Open Access
- 1 November 2001
- journal article
- Published by Elsevier
- Vol. 276 (44) , 40888-40895
- https://doi.org/10.1074/jbc.m106448200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Down-regulation of p21 WAF1/CIP1 or p27 Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cellsProceedings of the National Academy of Sciences, 2000
- Regulation of the Cdk inhibitor p27 and its deregulation in cancerJournal of Cellular Physiology, 2000
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1The EMBO Journal, 1997
- Ras Links Growth Factor Signaling to the Cell Cycle Machinery via Regulation of Cyclin D1 and the Cdk Inhibitor p27KIP1Molecular and Cellular Biology, 1997
- Cyclin E-CDK2 is a regulator of p27Kip1.Genes & Development, 1997
- Enhanced Ribosomal Association of p27Kip1 mRNA Is a Mechanism Contributing to Accumulation during Growth ArrestPublished by Elsevier ,1997
- Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell CycleScience, 1996
- Translational Control of p27 Kip1 Accumulation During the Cell CycleScience, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995